Fairmont Chateau Whistler Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2011


Here are the related meetings in 2018:
B Cells: Mechanisms in Immunity and Autoimmunity (E4)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

B Cells: New Insights into Normal versus Dysregulated Function (D6)


Organizer(s) David J. Rawlings, Frances E. Lund, Stuart G. Tangye and John G. Monroe
April 12—17, 2011
Fairmont Chateau Whistler • Whistler, British Columbia Canada
Abstract Deadline: Dec 13, 2010
Late Abstract Deadline: Jan 18, 2011
Scholarship Deadline: Dec 13, 2010
Early Registration Deadline: Feb 11, 2011

Sponsored by Amgen Inc.

Summary of Meeting:
B lymphocytes play crucial roles in host defense against infection via a series of highly coordinated processes that include cell homing, antigen recognition, antibody secretion, antigen presentation, and/or cytokine release. To accomplish these myriad functions, B cells must maneuver through a complex series of primary and secondary developmental, homoeostatic, and activation-triggered checkpoints. These checkpoints dictate stochastic and molecularly directed events dependent upon local micro-environments, cell-cell interactions, and interactions with pathogenic or non-pathogenic organisms. Early events in this developmental cascade promote the generation of a diverse B cell antigen receptor repertoire that is essential for both survival and entry into downstream effector populations. In parallel, this repertoire is tested for self-reactivity at multiple steps leading to either loss or expansion of specific clones. Dysregulation of these complex processes can lead, alternatively, to immunodeficiency, autoimmune, or malignant disease. The overall goal of this meeting is to highlight recent studies of normal versus abnormal B cell development and function with an emphasis whenever possible on data using human models.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


TUESDAY, APRIL 12

15:00—19:30
Registration

Macdonald Foyer
18:15—19:15
Refreshments

Macdonald Foyer
19:15—20:30
Welcome and Keynote Address
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* David J. Rawlings, University of Washington, Seattle Children's Hospital Research Institute, USA
Introduction

Christopher C. Goodnow, Garvan Institute of Medical Research, Australia
Mechanism of Actively Acquired Tolerance or Immunity: Progress and Problems 50 Years After the Burnet-Medawar Nobel Prize


WEDNESDAY, APRIL 13

07:00—08:00
Breakfast

Frontenac A B C
08:00—11:15
Conventional (or Adaptive) B Cell Development
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* John G. Monroe, Genentech, Inc., USA

Barbara Lynne Kee, University of Chicago, USA
E Protein Transcription Factors and Lymphoid Specification

Malay Mandal, University of Chicago, USA
Short Talk: Genetic and Epigenetic Repression of the Igkappa Intronic Enhancer by STAT5

Brian M. Iritani, University of Washington, USA
Short Talk: Identification of a Novel Metabolic Regulator Controlling B Lymphocyte Development

Harinder Singh, Cincinnati Children's Hospital Medical Center, USA
The Regulatory and Molecular Logic of IL-7R and pre-BCR Signaling in B Cell Development

Ann J. Feeney, The Scripps Research Institute, USA
Epigenetic and 3-Dimensional Regulation of Antibody Repertoire Formation

Robert C. Rickert, Pfizer, USA
Elimination of Self-Reactive B Cells by Follicular Dendritic Cell-Bound Antigen

09:20—09:40
Coffee Break

Macdonald Foyer
11:15—13:00
Poster Setup

Macdonald A B C
13:00—22:00
Poster Viewing

Macdonald A B C
11:15
On Own for Lunch

12:30—14:30
Workshop 1A: Tonic and Naive B Cell Signaling

MacDonald D
Anselm Enders, John Curtin School of Medical Research, Australia
ATP11c is Critical for Phosphatidylserine Internalization and B Lymphocyte Differentiation

Julie Zikherman, University of California, San Francisco, USA
Titration of CD45 Expression Regulates Sequential Tolerance Checkpoints during B Cell Development

* Randall S. Davis, University of Alabama, Birmingham, USA
FCRL5 has Dual Modulatory and Compartment-Specific Influence on Innate-Like B Cell Receptor Signaling

Haewon Sohn, NIAID, National Institutes of Health, USA
The Potential of FcRL4 to Function as an Adaptive to Innate Molecular Switch in Exhausted Memory B Cells

Mary Kaileh, NIH/NIA, USA
PI3K-Dependent Production of NF-kappaB2 Protein by Tonic B Cell Receptor Signaling Mediates Effective Responsiveness to BAFF

Edina Andrea Schweighoffer, Francis Crick Institute - Mill Hill Laboratory, UK
BCR Tonic Signalling and B Cell Survival

Emilie Jacque, National Institute for Medical Research, UK
IKK-Induced NF-kappaB1 p105 Proteolysis is Essential for Mature B Cell Function in T-Dependent and T-Independent Immune Responses

12:30—14:30
Workshop 1B: Germinal Cell Biology

MacDonald EF
* Ann M. Haberman, Yale University School of Medicine, USA

Darran G. Cronshaw, Feinstein Institute for Medical Research, USA
Grb2 Signaling in B Cells Controls Lymphoid Follicle Organization and Germinal Center Reaction

* Troy D. Randall, University of Alabama at Birmingham, USA
IL-17 Controls Ectopic Lymphoid Tissue Development

Neda Nikbakht, Thomas Jefferson University, USA
Cell-Cell Interactions Associated with the Intrafollicular B Cell Migratory Program Required for Initiation of Germinal Centers

Saya Moriyama, RIKEN, Research Center for Allergy and Immunology, Japan
BCL6 Protein Expression Shapes Pre-Germinal Center B Cell Dynamics and Follicular Helper T Cell Heterogeneity

Natalia Sol Chaimowitz, Virginia Commonwealth University, USA
ADAM10 is Critical for Germinal Center Formation and Antibody Responses

Elissa K. Deenick, Garvan Institute of Medical Research, Australia
Follicular Helper T Cell Differentiation Requires Continuous Antigen Presentation but not a Unique B Cell Signal

Uttiya Basu, Columbia University, USA
Regulation of Activation Induced Deaminase DNA Deamination Activity by Non-Coding RNA Surveillance Pathway

Shengli Xu, Bioprocessing Technology Institute, Singapore
The RNase III Enzyme Dicer is Essential for Germinal Center B Cell Formation during T Cell-Dependent Immune Response

14:30—16:30
Workshop 1C: Autoimmunity and Immunodeficiency I (Mechanisms of Autoimmunity and Human Disease)

MacDonald EF
* Anne B. Satterthwaite, University of Texas Southwestern Medical Center, USA

* Shiv Pillai, Massachusetts General Hospital, USA

Anatoly V. Rubtsov, University of Colorado Health Sciences Center, USA
TLR7 Signaling Drives the Accumulation of a Novel CD11c+ B Cell Population that is Critical for the Development of Autoimmunity

Maria A. Gutierrez, University of Texas Southwestern Medical Center, USA
Role of Bruton’s Tyrosine Kinase (Btk) and IL-6 in Regulating Plasma Cell Accumulation and IgG Autoantibody Production in lyn-/- Mice

Isis Ludwig-Portugall, Institute of Experimental Immunology, Germany
Autoantibody Production, Expansion and Survival of Autoreactive B Cells against Non Lymphoid Tissue Ag is Controlled by Ag Specific Treg

Allison L. Sang, University of Colorado Denver, USA
Antigen Specific and Non-Specific Activation of Rheumatoid Factor B-Cells in the Triple Congenic Mouse Model of Lupus

Edgar D. Charles, Rockefeller University, USA
Somatic Hypermutations Confer Rheumatoid Factor Activity in Hepatitis C Virus-Associated Mixed Cryoglobulinemia

Nathalie Bonnefoy-Berard, INSERM U851, France
Role of IL-17 and BAFF in B Cell Biology and Systemic Lupus Erythematosus (SLE) Pathophysiology

Yuri Fedoriw, University of North Carolina, USA
Decreased TdT+ Bone Marrow B Cell Precursors after Allogeneic Stem Cell Transplantation is Associated with Development of Human Chronic Graft versus Host Disease (cGVHD)

Kendra N. Taylor, Massachusetts General Hospital, USA
Utilizing the Surface 9-O-Acetylation State of B-Cells to Classify SLE Patients

16:30—17:00
Coffee Available

Macdonald Foyer
17:00—19:00
B Cell Activation and Co-Receptor Signaling
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* David J. Rawlings, University of Washington, Seattle Children's Hospital Research Institute, USA

Tomohiro Kurosaki, WPI Immunology Frontier Research Center, Osaka University, Japan
Function of Store-Operated Calcium Entry in B Lymphocytes

Facundo D. Batista, Ragon Institute of MGH, MIT and Harvard, USA
Early Events in B Cell Activation: From Single Molecules to Living Tissue

Jürgen Wienands, Georg August University of Goettingen, Germany
Activation Signals for Naïve and Class-switched Memory B Cells

Wanli Liu, Tsinghua University, China
Short Talk: The Tale of a Tail: The Role of Disk Large Homolog 1 (Dlg1) in Isotype-Switched IgG-BCR Signaling

19:00—20:00
Social Hour with Lite Bites

Macdonald A B C
19:30—22:00
Poster Session 1

Macdonald A B C

THURSDAY, APRIL 14

07:00—08:00
Breakfast

Frontenac A B C
08:00—11:15
Innate B Cells
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* John F. Kearney, University of Alabama, Birmingham, USA

Kenneth A. Dorshkind, University of California, Los Angeles, USA
B Cell Developmental Programs from Embryogenesis through Senescence

Nicole Baumgarth, University of California, Davis, USA
Innate Regulation of B-1 Cell Responses to Influenza Infection

Thomas L. Rothstein, Western Michigan University, USA
Short Talk: Human B1 Cells Express the Novel Phenotype: CD20+CD27+CD43+CD70-

Andrea Cerutti, Mount Sinai School of Medicine, USA
Innate Signaling Networks in Memory B Cell Responses

Ralf Küppers, University of Duisburg-Essen, Medical School, Germany
Human B Cell Subsets and the Cellular Origin of Chronic Lymphocytic Leukemia

Yi Hao, Huazhong University of Science & Technology, China
Short Talk: An Innate-Like B Cell Subset Expands with Age

09:20—09:40
Coffee Break

Macdonald Foyer
11:15—13:00
Poster Setup

Macdonald A B C
13:00—22:00
Poster Viewing

Macdonald A B C
11:15
On Own for Lunch

12:30—14:30
Workshop 2A: Autoimmunity and Immunodeficiency II (Tolerance Checkpoints and Novel Therapies)

Macdonald EF
* Nina Luning Prak, University of Pennsylvania, USA

Wenzhao Meng, University of Pennsylvania, USA
VH Gene Selection at the Pro-B to Pre-B Cell Transition in C57BL6/J Mice

Sarah F. Andrews, National Institutes of Health, USA
B Cell Receptor Light Chain Specificity Strongly Influences Mechanisms of B Cell Tolerance

Lisa M. Russell, NIA, National Institutes of Health, USA
The Transcription Factor Ets-1 is Required for Peripheral B Cell Tolerance to Self-Antigens

Xuezhi Dai, Seattle Childrens' Research Institute, USA
Developmentally Regulated Control of MEF2C Limits Early Transitional B Cell Response to BCR Crosslinking

* Roberta Pelanda, University of Colorado Denver, USA
Human B Cell Development and Selection in Hematopoietic Humanized Mice

Ian R. Hardy, National Jewish Health, USA
Therapeutic Benefit of anti-CD79b Antibodies

Charlotte M. Starke, University Erlangen-Nuremberg, Germany
Autoreactive Short- and Long-Lived Plasma Cells within Nephritic Kidneys of Lupus Mice are Susceptible to Bortezomib

Rachel H. Bonami, Vanderbilt University, USA
Autoantigen-Targeted Therapy Removes Anti-Insulin B Lymphocytes that Escape Immune Tolerance Checkpoints in Type 1 Diabetes-Prone NOD Mice

12:30—14:30
Workshop 2B: Regulatory and Innate B Cells

MacDonald D
* Thomas L. Rothstein, Western Michigan University, USA

* Elizabeth A. Leadbetter, University of Texas Health Science Center, USA
IL-21-Producing iNKT Cells Direct a Novel B Cell Response to a Cognate Lipid Antigen

Sara M. Lind Enoksson, Karolinska Institutet, Sweden
IL-18 Induces Natural Antibody Responses Regulated by NKT Cells

Jelle de Wit, Sanquin Research, Netherlands
B Cells Phagocytosing Bacteria Solicit Aid for Antibody Production by Induction of IL-21 in a Novel IFN-gamma+/IL-21+ Th1 Subset Suppressing Detrimental IL-4 Expression

Luciën E.P.M van der Vlugt, Leiden University Medical Center, Netherlands
IL-10 Producing Splenic B Cells are Involved in Schistosome-Induced Protection against Allergic Airway Inflammation

Sylvie Amu, Trinity College Dublin, Ireland
Helminth-Induced B Effector and B Regulatory Cells have Differential Effects in Experimental Autoimmune Encephalomyelitis

Marc Seifert, University of Duisburg-Essen, Germany
Molecular Analysis of Human Peripheral Blood CD5+ B Cells: The Existence of CD5+ Post-Germinal Center Memory B Cells

Eliver Eid Bou Ghosn, Stanford University, USA
Distinct Progenitors for B-1 and B-2 Cells are Present in Adult Mouse Spleen

Daniel O. Griffin, Feinstein Institute, USA
Human B1 Cell Immunoglobulin Specificity: When Less is More

14:30—16:30
Workshop 2C: Plasma Cells and Antibody Response/Repertoire

MacDonald EF
* David M. Allman, University of Pennsylvania, USA

* John F. Kearney, University of Alabama, Birmingham, USA
Modulation of Type 1 Diabetes by Anti-N-acetyl-D-glucosamine Antibodies

David R. Fooksman, Albert Einstein College of Medicine, USA
Development and Migration of Pre-Plasma Cells in the Mouse Lymph Node

Bertrand Huard, Centre Medical Universitaire, Switzerland
Myeloid Precursor Cells Promote Plasma-Cell Survival by Constitutively Secreting APRIL in the Bone Marrow

Nicholas A. Barnes, Leeds Institute of Molecular Medicine, UK
BLIMP-1 Represses miR-21 During Plasma Cell Differentiation

Henrik E. Mei, German Rheumatism Research Center, Germany
Chronic Differentiation of Human Mucosal IgA-Secreting Cells during B Cell Depletion Therapy with Rituximab

Huizhong Xiong, Genentech, USA
High Affinity IgE Antibody Generation Requires an IgG Germinal Center Phase

David M. Allman, University of Pennsylvania, USA
Long-Lived CD19+ Plasma Cells Induced with a T Cell Independent Antigen

Zhiyong Yang, University of California, San Francisco, USA
A Novel Fluorescent Reporter for Tracking IgE+ B Cells in vivo

16:30—17:00
Coffee Available

Macdonald Foyer
17:00—19:00
Effector and Regulatory B Cell Function
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* Anthony L. DeFranco, University of California, San Francisco, USA

Frances E. Lund, University of Alabama at Birmingham, USA
Impairment of Dendritic Cell, CD4 T Cell and CD8 T Cell Mediated Immune Responses following B Cell Depletion

David Gray, University of Edinburgh, UK
Programming and Regulation of T Cells by B Cells

Claudia Mauri, University College London, UK
Regulatory B Cell in Health and Disease

Wei Xu, Roche Innovation Center Zurich, Switzerland
Short Talk: Macrophages Induce Terminal Differentiation of Plasma Cells through CXCL10/IP-10

19:00—20:00
Social Hour with Lite Bites

Macdonald A B C
19:30—22:00
Poster Session 2

Macdonald A B C

FRIDAY, APRIL 15

07:00—08:00
Breakfast

Frontenac A B C
08:00—11:15
GC Reaction and B Cell Memory
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* Stuart G. Tangye, Garvan Institute of Medical Research, Australia

David M. Tarlinton, Monash University, Australia
Memory B Cell and Plasma Cell Differentiation

Jesse Green, University of California, San Francisco, USA
Short Talk: S1P-Receptor 2 Regulation of Germinal Center B Cell Growth

Claudia Berek, Deutsches Rheuma Forschungszentrum, Germany
Short Talk: Eosinophils are Required for the Long-Term Survival of Plasma Cells in the Bone Marrow

Anthony L. DeFranco, University of California, San Francisco, USA
Selective Utilization of TLR/MyD88 Signaling in B Cells for Enhancement of the Anti-Viral Germinal Center Response

Carola G. Vinuesa, Australian National University, Australia
Tfh Cells and Memory B Cell Selection

Ann M. Haberman, Yale University School of Medicine, USA
Short Talk: Inter-Follicular Germinal Center B Cell and T Follicular Helper Cell Development Precedes Follicular Tfh Maintenance

Kathryn A. Pape, University of Minnesota, USA
Short Talk: Different B Cell Populations Mediate Early and Late Memory during an Endogenous Immune Response

09:20—09:40
Coffee Break

Macdonald Foyer
11:15—13:00
Poster Setup

Macdonald A B C
13:00—22:00
Poster Viewing

Macdonald A B C
11:15
On Own for Lunch and Recreation

16:30—17:00
Coffee Available

Macdonald Foyer
17:00—19:00
GC Transcriptional Programs and Alterations in B Lymphoma
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* Ralf Küppers, University of Duisburg-Essen, Medical School, Germany

Ari M. Melnick, Weill Cornell Medical College, USA
Transcriptional Programming in Normal and Malignant Germinal Center B Cells

Rafael Casellas, NIAMS-NCI, National Institutes of Health, USA
Seq-ing AID in B Cell Tumor Development

Louis M. Staudt, National Cancer Institute, NIH, USA
Converging on the Achilles Heel of Lymphoma through Functional and Structural Genomics

Soungchul Cha, MD Anderson Cancer Center, USA
Short Talk: Nonstereotypic Follicular Lymphoma B-Cell Receptors Recognize Vimentin as a Shared Autoantigen

19:00—20:00
Social Hour with Lite Bites

Macdonald A B C
19:30—22:00
Poster Session 3

Macdonald A B C

SATURDAY, APRIL 16

07:00—08:00
Breakfast

Frontenac A B C
08:00—11:15
B Cell Genetic Alterations Linked to Cell Intrinsic Autoimmunity and/or Immunodeficiency
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* Christopher C. Goodnow, Garvan Institute of Medical Research, Australia

Edward K. Wakeland, University of Texas Southwestern Medical Center, USA
B Cell Function in Murine Models of SLE

Jane H. Buckner, Benaroya Research Institute at Virginia Mason, USA
PTPN22 Modulates B Cell Tolerance in Human Autoimmunity

David J. Rawlings, University of Washington, Seattle Children's Hospital Research Institute, USA
WASp-/- B Cells Promote Humoral Autoimmunity

Kerstin Nündel, University of Massachusetts Medical School, USA
Short Talk: Self-Ligand Dependent Selection of Rheumatoid Factor B Cells into the Marginal Zone Compartment

Tyani D. Chan, Garvan Institute of Medical Research, Australia
Short Talk: Molecular Mimicry and the Production of Autoantibody via the Germinal Centre Reaction

Stuart G. Tangye, Garvan Institute of Medical Research, Australia
Consequences of Loss-of Function Mutations in Primary Immunodeficiencies on Human B Cell Differentiation and Long-Lived Humoral Immunity

09:00—09:20
Coffee Break

Macdonald Foyer
11:15
On Own for Lunch

12:30—14:30
Workshop 3A: B Cell Lymphoma and Leukemia

Macdonald D
* Micah A. Luftig, Duke University Medical Center, USA
An ATM/Chk2 DNA Damage Response Suppresses EBV Mediated B Cell Transformation

Elizabeth Rose Walsh, NIAID, National Institutes of Health, USA
Requirements for B-T Cell Interactions in the Development of a TLR7 Transgenic Model of Systemic Autoimmune Disease

Casey D. Katerndahl, University of Minnesota, USA
A Pre-BCR/NF-kappaB Pathway Suppresses STAT5-dependent Pre-B Cell Leukemia

Joseph D. Dekker, University of Texas at Austin, USA
Investigating the Role of the Bcl11a Transcription Factor in Hematopoietic Development and Diffuse Large B Cell Lymphomas

* Arthur L. Shaffer III, NCI, National Institutes of Health, USA
The IRF4-SPIB Interface as a Therapeutic Target in Diffuse Large B-Cell Lymphoma

Nathalie Faumont, CNRS UMR 7276, France
Differential Weight and Function of RelA and RelB NF-kappaB Complexes in Both EBV-Transformed B-Cells and Activated B-Cell-Like Diffuse Large B-Cell Lymphomas

Michele Ceribelli, NCI, National Institutes of Health, USA
TCF4 Addiction in Activated B-Cell Like Diffuse Large B-Cell Lymphomas

Albert Gutierrez, Mayo Clinic College of Medicine, USA
CLL Lymph Node Proliferation Centers: A Role for BCR Signaling

12:30—14:30
Workshop 3B: B Cell Activation and Homeostasis

MacDonald EF
* Aaron J. Marshall, University of Manitoba, Canada

* Lars Nitschke, University of Erlangen, Germany
Regulation of B Cell Activation by Inhibitory Receptors and the Adaptor Protein Grb2

Marion Lösing, University of Goettingen, Germany
The Dok-3/Grb2 Module Accentuates Negative Regulatory Functions of Lyn in Antigen-Activated B Cells

Berit Jungnickel, Friedrich Schiller University Jena, Germany
A Critical Role for p53 in the Germinal Center Reaction

Ivan P. Landego, University of Manitoba, Canada
Role of TAPP-PI(3,4)P2 Interactions in B Cell Activation and Differentiation

Vivian M. Turner, Garvan Institute, Australia
The Role of TRAF2, TRAF3, cIAP1 and cIAP2 during Early and Late Antigen-Specific B Cell Responses

Yuanyuan Chu, Max Planck Institute of Biochemistry, Germany
B Cells Lacking the Tumor Suppressor TNFAIP3/A20 Display Impaired Differentiation, Hyperactivation and Cause Inflammation and Autoimmunity in Aged Mice

Rebecca Winkelmann, Nikolaus-Fiebiger Center for Molecular Medicine, Germany
B Cell Homeostasis and Plasma Cell Homing Controlled by Krüppel-Like Factor 2

Kristen L. Hoek, Vanderbilt University, USA
Follicular B Cell Trafficking Within the Spleen Actively Restricts Humoral Immune Responses

14:30—16:30
Workshop 3C: Memory B Cells and Modeling B Cell Responses

MacDonald EF
* Menno C. van Zelm, Monash University, Australia

* Leonore A. Herzenberg, Stanford University, USA
Antigen-Specific Memory in B-1a: A New Take on the Sources of Natural Antibody Production

Andrew L. Rankin, FivePrime, USA
IL-21R is Necessary for Normal Development of the Memory B Cell Response

Sandra Weller, Faculte de Medecine Necker-Enfants Malades, France
IgM+IgD+CD27+ B Cells Development and/or Homeostasis Requires IRAK4-Myd88 Dependent but TLR9-Independent Signals in Humans

Magdalena A. Berkowska, Leiden University Medical Center, Netherlands
Novel Insights into Germinal Center-Dependent and –Independent Maturation Pathways by Molecular Analysis of Human Memory B-Cell Subsets

* Deborah Dunn-Walters, University of Surrey, UK
High Throughput Immunoglobulin Repertoire Analysis Distinguishes between Human IgM Memory and Switched Memory B Cell Populations

George Georgiou, University of Texas at Austin, USA
System-Level Organization and Dynamics of B cell Responses as Revealed by NextGen Sequencing of V Repertoires from B Lymphocytes Subpopulations in Healthy and Diseased Individuals

Justin J. Taylor, Fred Hutchinson Cancer Research Center, USA
Prolonged G1-Arrest Precedes Quiescence during Memory B Cell Differentiation

Jamie L. Duke, Yale University, USA
Computational Analysis of Genome-Wide Somatic Hypermutation

16:30—17:00
Coffee Available

Macdonald Foyer
17:00—19:00
Manipulation of B Cells in Human Disease
Meeting has ended...abstracts no longer viewable online.

Macdonald D E F
* Frances E. Lund, University of Alabama at Birmingham, USA

Anne Davidson, Feinstein Institute for Medical Research, USA
BAFF Inhibition in SLE

Susan Moir, NIAID, National Institutes of Health, USA
Immunopathogenesis of B Cells in HIV Infection

Jason Ho, NIAID, National Institutes of Health, USA
Short Talk:

Patrick C. Wilson, University of Chicago, USA
The Human B Cell Response to Annual and H1N1 Influenza Virus

19:00—20:00
Social Hour with Lite Bites

Macdonald A B C
20:00—23:00
Entertainment

Macdonald A B C

SUNDAY, APRIL 17

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI094881-01




We gratefully acknowledge additional support for this conference from:

Educational donation provided by Amgen

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Genentech, Inc.


Genentech, Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676